pipette
ENEnglish

Distinct tau PET dynamics in early versus late age-of-onset Alzheimer’s disease

Konstantinos Chiotis, Ganna Blazhenets, David N. Soleimani‐Meigooni, Paul S. S Aisen, Alinda N. Amuiri, Alireza Atri, Laurel A. Beckett, Michael J. Brickhouse, David Glenn Clark, Jeffrey L. Dage, Gregory Scott Day, Ranjan Duara, Ani Eloyan, Tatiana Foroud, Neill R. Graff‐Radford, Ian M. Grant, Dustin B. Hammers, Lawrence S. Honig, Erik C. B. Johnson, David Thomas Jones, Kala Kirby, Robert A. Koeppe, Joel H. Kramer, Walter A. Kukull, Julien Lagarde, Antoine Leuzy, Piyush Maiti, Joseph C. Masdeu, Mario F. Mendez, Erik S. Musiek, Kelly Nicole Holohan Nudelman, Chiadi U. Onyike, Meghan Riddle, Salma Rocha, Emily Joy Rogalski, Stephen Salloway, Daniel R. Schonhaut, Sharon J. Sha, Ranjani P. Shankar, Alexander Taurone, Maryanne Thangarajah, Arthur W. Toga, Alexandra Touroutoglou, Raymond Scott Turner, Prashanthi Vemuri, Thomas S. Wingo, David A. Wolk, Kyle B. Womack, Jiaxiuxiu Zhang, María C. Carrillo y 4 más

Revista con revisión por pares

En palabras de los autores

Early-onset Alzheimer's disease (EOAD) and Late-onset AD (LOAD) differ in clinical presentations and rates of progression. We aimed to compare baseline and longitudinal tau PET burden, and their relationship with clinical variables in amyloid-PET positive, cognitively impaired participants from the Longitudinal Early-Onset Alzheimer's Disease Study (EOAD; n=390) and Alzheimer's Disease Neuroimaging Initiative (LOAD; n=211). Patients with EOAD showed higher baseline tau PET retention, broader neuroanatomical involvement and faster accumulation rates over time compared to LOAD, after adjusting for amyloid load and clinical stage. Tau PET showed stronger correlations with baseline amyloid burden and clinical measures of global cognition and function in EOAD than LOAD. We conclude that earlier age of onset in AD is linked to a more aggressive tauopathy, which in turn is a primary driver of clinical decline. These findings suggest that optimal therapeutic targets and strategies may differ between EOAD and LOAD.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 6 de noviembre. Science Translational Medicine. Revista con revisión por pares.

DOI: 10.1126/scitranslmed.aea2816